Stocktoria

Natera, Inc. NTRA

Nasdaq · stock · Services-Medical Laboratories · website · IPO 2015-07-02 · LEI

Natera, Inc. financials (annual)

Revenue
$217.1M $210.9M $257.7M $302.3M $391.0M $625.5M $820.2M $1.08B $1.70B $2.31B 2016201720182019202020212022202320242025
Net income
-$100.3M -$137.6M -$128.2M -$124.8M -$229.7M -$471.7M -$547.8M -$434.8M -$190.4M -$208.2M 2016201720182019202020212022202320242025
Free cash flow
-$97.2M -$107.7M -$74.5M -$68.4M -$202.1M -$376.3M -$479.2M -$286.2M $69.2M $109.1M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$2.3B$1.7B$1.1B$820.2M$625.5M$391.0M$302.3M$257.7M$210.9M$217.1M
R&D expense$624.1M$404.1M$320.7M$316.4M$264.2M$100.0M$51.4M$51.4M$50.1M$41.9M
SG&A expense$1.2B$841.3M$618.3M$588.6M$511.0M$303.6M$206.2M$154.9M$155.3M$136.1M
Operating income-$309.9M-$222.3M-$446.2M-$541.0M-$468.2M-$216.3M-$116.3M-$114.6M-$135.3M-$101.0M
Interest expense$4.1M$10.7M$12.6M$9.3M$8.3M$15.1M$10.7M$10.5M$4.2M$533,000
Income tax-$59.9M$695,000$271,000$978,000$618,000$98,000$2.0M$321,000$454,000$142,000
Net income-$208.2M-$190.4M-$434.8M-$547.8M-$471.7M-$229.7M-$124.8M-$128.2M-$137.6M-$100.3M
EPS (diluted)$-1.52$-1.53$-3.78$-5.57$-5.21$-2.84$-1.79$-2.22$-2.59$-1.95
Operating cash flow$215.3M$135.7M-$247.0M-$431.5M-$335.2M-$182.5M-$63.4M-$70.6M-$97.8M-$74.1M
Free cash flow$109.1M$69.2M-$286.2M-$479.2M-$376.3M-$202.1M-$68.4M-$74.5M-$107.7M-$97.2M
Cash & equivalents$466.0M$84.4M$48.7M$61.9M$46.4M$12.6M$15.3M
Inventory$68.4M$44.7M$40.8M$35.4M$26.9M$20.0M$12.4M$13.6M$9.0M$6.4M
Total assets$2.4B$1.7B$1.4B$1.4B$1.2B$932.2M$582.7M$268.2M$214.6M$210.7M
Total liabilities$685.9M$465.3M$676.4M$688.7M$583.2M$445.9M$303.9M$236.0M$189.2M$104.2M
Shareholders' equity$1.7B$1.2B$765.3M$705.7M$653.3M$486.2M$278.7M$32.2M$25.4M$143.6M

Growth · year-over-year · Revenue CAGR 30%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth+35.9%+56.7%+32.0%+31.1%+60.0%+29.3%+17.3%+22.1%-2.8%+14.0%
Free cash flow growth+57.6%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.